A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.
about
Anti-angiogenic alternatives to VEGF blockadeIntegrins in cancer: biological implications and therapeutic opportunitiesNitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling.Ligand-independent activation of c-Met by fibronectin and α(5)β(1)-integrin regulates ovarian cancer invasion and metastasis.Endothelial alpha5 and alphav integrins cooperate in remodeling of the vasculature during developmentMesothelial cells promote early ovarian cancer metastasis through fibronectin secretion.Understanding molecular mechanisms in peritoneal dissemination of colorectal cancer : future possibilities for personalised treatment by use of biomarkers.alpha5beta1-integrin expression is essential for tumor progression in experimental lung cancer.Anti-vascular therapies in ovarian cancer: moving beyond anti-VEGF approaches.Tumor angiogenesis in the absence of fibronectin or its cognate integrin receptors.Fibronectin induces endothelial cell migration through β1 integrin and Src-dependent phosphorylation of fibroblast growth factor receptor-1 at tyrosines 653/654 and 766.β1-integrins signaling and mammary tumor progression in transgenic mouse models: implications for human breast cancer.Beta 1 integrin predicts survival in breast cancer: a clinicopathological and immunohistochemical study.Integrins and metastasis.β1 Integrin as a Prognostic and Predictive Marker in Triple-Negative Breast CancerMonoclonal antibodies in the treatment of pancreatic cancer.Novel strategies for the treatment of chondrosarcomas: targeting integrins.Jekyll and Hyde: the role of the microenvironment on the progression of cancer.Integrin modulators: a patent review.Integrin α5β1, the Fibronectin Receptor, as a Pertinent Therapeutic Target in Solid Tumors.Matrix control of pancreatic cancer: New insights into fibronectin signalingMembrane proteome analysis of glioblastoma cell invasion.Understanding the role of structural integrity and differential expression of integrin profiling to identify potential therapeutic targets in breast cancer.β1 integrins mediate resistance to ionizing radiation in vivo by inhibiting c-Jun amino terminal kinase 1.Integrin VLA-5 and FAK are Good Targets to Improve Treatment Response in the Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia.Alterations in Cell-Extracellular Matrix Interactions during Progression of Cancers.uPAR: a modulator of VEGF-induced angiogenesis.Integrin α5 triggers the metastatic potential in renal cell carcinoma.β1 and β3 integrins in breast, prostate and pancreatic cancer: A novel implication.CD93 promotes integrin-β1 activation and fibronectin fibrillogenesis during tumor angiogenesis.Anti-Tumorigenic and Anti-Metastatic Activity of the Sponge-Derived Marine Drugs Aeroplysinin-1 and Isofistularin-3 against Pheochromocytoma In Vitro.
P2860
Q26775947-4EE4E077-EAF5-44ED-8202-24940CFF3782Q29614536-59E5C05B-B45F-4188-AC80-285CEB2D0361Q30008769-5050E7A2-2CBE-4BA7-AD63-B87917FE5C3AQ30430565-6B8ED171-3CA3-42A5-8FE6-38EF89376728Q33929646-09845891-03DB-4F83-8C1D-A2C19878E7D7Q34311697-904F4FD1-FC68-4772-938C-ADF298FA4BACQ34348691-CA248980-271E-4E8F-8053-5AC7EFD2F242Q34357105-C99D34C7-B86E-4530-8A97-AD7072C0F1FAQ35205410-BA1ED39D-F5D0-49D4-A73D-69CB0D247EA3Q35217119-3327261D-4D01-41C8-92C5-763FF546D288Q35801970-A2D83438-A74E-4339-AB83-137BFA9662CFQ35889538-7FD10FF0-A412-4E56-98FD-C190757AE41DQ36468724-ADE3ADCF-9992-43FC-AF16-83B48770E40CQ37014793-69B9FF36-B8A2-4C23-8043-2F1C830983CCQ37286353-10289F60-937A-4AC7-9043-DBB606641B02Q37355568-6A23C244-83B9-40A0-8A05-72C3E629279AQ37486731-CFEEE883-2734-4241-979C-45A272195043Q37815128-421AE45B-80E6-4466-86C9-4261392A2D64Q38139612-84040A1A-5F95-4733-A000-91C1CCB58D90Q38161726-A23BB0A5-7F55-4B04-B20B-1CFCAADE60CCQ38689584-CE6A63EE-7048-4F79-87E8-EA9FAF8EAFADQ38889754-B7B3DB07-191F-4F0E-AD12-84D13F8D49C1Q39102273-038F8750-A579-4594-864A-5D70E3AFEBEFQ39202802-D5076A7D-4A70-4BB2-9B6D-441E9995AAA5Q39852454-09C28940-F045-4162-B954-81D5580A62D2Q40441025-C7CD09ED-47B1-4BB9-B08A-84E0CB74CFE0Q42726309-E8430CCB-C96F-4CC8-888D-6C46DCD2AF95Q47140682-B2F099EE-CCB5-464B-B6EA-69CC0CA76F37Q52647715-D83E7462-26BB-4E49-BA34-422BD15547A9Q54979076-7D10260A-1E2B-46EA-BC26-9E8809064D39Q55331747-D1D446AD-7C78-4309-8769-B0C7735922B6
P2860
A function blocking anti-mouse integrin alpha5beta1 antibody inhibits angiogenesis and impedes tumor growth in vivo.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
A function blocking anti-mouse ...... impedes tumor growth in vivo.
@ast
A function blocking anti-mouse ...... impedes tumor growth in vivo.
@en
type
label
A function blocking anti-mouse ...... impedes tumor growth in vivo.
@ast
A function blocking anti-mouse ...... impedes tumor growth in vivo.
@en
prefLabel
A function blocking anti-mouse ...... impedes tumor growth in vivo.
@ast
A function blocking anti-mouse ...... impedes tumor growth in vivo.
@en
P2093
P2860
P356
P1476
A function blocking anti-mouse ...... impedes tumor growth in vivo.
@en
P2093
David Powers
Debra T Chao
Dong Zhang
Melanie H L Wong
Melvin Fox
Pauline E Wales
Robert B Dubridge
Vanitha Ramakrishnan
Vinay Bhaskar
P2860
P2888
P356
10.1186/1479-5876-5-61
P577
2007-11-27T00:00:00Z
P5875
P6179
1000852446